The American Society for Radiation Oncology (ASTRO) recently selected 12 of its members to become Fellows of the American Society for Radiation Oncology, a prestigious cancer organization with more than 10,000 members who specialize in treating patients with radiation therapy.
Jeffrey Wong, M.D., chair and professor of City of Hope’s Department of Radiation Oncology, will receive his FASTRO designation November 3, 2009, at a special ceremony during the Society’s 51th Annual Meeting scheduled for November 1-5, 2009, at McCormick Place West in Chicago.
“The ASTRO Fellows program was created as a way to recognize the best and the brightest in the field of radiation oncology,” said Timothy Williams, ASTRO president and a radiation oncologist at Boca Raton Community Hospital in Boca Raton, Fla. “Dr. Jeffrey Wong is an example of someone who has gone above and beyond in his efforts to help the specialty, the Society and the patients we all work so hard to cure.”
Wong is a leading expert in the use of targeted radiation therapy using radio-labeled antibodies for colorectal cancer, breast cancer, and lung cancer. He is also recognized for his efforts in targeted therapy using image-guided intensity modulated radiation therapy, applying this method in bone marrow transplant procedures to potentially minimize total body irradiation and lessen side effects.
He performed one of the first total marrow irradiation procedures in the treatment of myeloma using TomoTherapy, a system that delivers targeted beams of radiation to affected areas minimizing radiation exposure to the surrounding healthy tissue and organs. Wong has authored over 100 studies in peer-reviewed journals including the Journal of Clinical Oncology, the International Journal of Radiation Oncology, Biology, and Physics and Cancer Research, and delivered numerous abstracts and presentations.
He is listed in the national health care guide for consumers “America’s Top Doctors for Cancer.” He is board-certified and a member of the American Society for Therapeutic Radiology Oncology and the American Society of Clinical Oncology.
Members of ASTRO are eligible to become a Fellow if they have been a member of the Society for at least 20 years, served in a leadership role for the organization and have made a significant contribution to the field of radiation oncology.
The nominations were reviewed by a nine member Fellows Selection Committee who made recommendations to the ASTRO Board of Directors to make the final decision.